We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUOT
3726
DELISTED
Quotient Technology Inc
QUOT
$37.6K ﹤0.01%
10,953
FCX icon
3727
PUT
Freeport-McMoran
FCX
$96.4B
$37.4K ﹤0.01%
+17,100
New +$598K
WRAP icon
3728
Wrap Technologies
WRAP
$104M
$37.3K ﹤0.01%
22,100
-1,000
-4% -$1.82K
WE
3729
DELISTED
WeWork Inc.
WE
$36K ﹤0.01%
630
-25
-4% -$2.34K
CMU
3730
DELISTED
MFS High Yield Municipal Trust
CMU
$35.7K ﹤0.01%
11,415
-6,597
-37% -$20.2K
TSP
3731
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$35.7K ﹤0.01%
21,776
-11,308
-34% -$40.3K
CMCSA icon
3732
CALL
Comcast
CMCSA
$91B
$34.4K ﹤0.01%
69,400
-7,000
-9% -$232K
ICAD
3733
DELISTED
iCAD Inc
ICAD
$33.9K ﹤0.01%
18,546
-2,104
-10% -$3.92K
LASR icon
3734
CALL
nLIGHT
LASR
$2.84B
$33.9K ﹤0.01%
+25,100
New +$259K
SLGC
3735
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$32.8K ﹤0.01%
+13,070
New +$36.5K
SNV
3736
CALL
DELISTED
Synovus
SNV
$32.2K ﹤0.01%
42,900
-1,200
-3% -$47.6K
BSX icon
3737
CALL
Boston Scientific
BSX
$74.2B
$31.4K ﹤0.01%
+26,000
New +$1.13M
CCO icon
3738
Clear Channel Outdoor Holdings
CCO
$1.23B
$31.4K ﹤0.01%
29,900
+13,000
+77% +$16.4K
PVLA
3739
Palvella Therapeutics
PVLA
$2.22B
$31.2K ﹤0.01%
375
+125
+50% +$10K
EVLV icon
3740
Evolv Technologies
EVLV
$1.08B
$31.1K ﹤0.01%
12,000
-200
-2% -$589
HD icon
3741
CALL
Home Depot
HD
$353B
$30.8K ﹤0.01%
14,200
-14,500
-51% -$4.42M
ELVT
3742
DELISTED
Elevate Credit, Inc.
ELVT
$30.6K ﹤0.01%
17,484
FBIO icon
3743
Fortress Biotech
FBIO
$86.7M
$29.1K ﹤0.01%
2,965
DWSN icon
3744
Dawson Geophysical
DWSN
$138M
$28.6K ﹤0.01%
14,593
MKTW icon
3745
MarketWise
MKTW
$52.8M
$28.5K ﹤0.01%
849
OMC icon
3746
CALL
Omnicom Group
OMC
$23.6B
$28.5K ﹤0.01%
17,800
-100
-0.6% -$7.42K
EMAN
3747
DELISTED
eMagin Corporation
EMAN
$28.3K ﹤0.01%
33,333
FTH
3748
Faeth Therapeutics
FTH
$773M
$28.3K ﹤0.01%
950
LMDX
3749
DELISTED
LumiraDx Limited Common Shares
LMDX
$27.7K ﹤0.01%
30,755
-234,063
-88% -$247K
MVIS icon
3750
Microvision
MVIS
$86.6M
$27.4K ﹤0.01%
776
-19
-2% -$883

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.